Page last updated: 2024-08-24

kynostatin 272 and Disease Models, Animal

kynostatin 272 has been researched along with Disease Models, Animal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, BD; Balis, FM; Farley, MQ; Godwin, K; Jarosinski, P; McCully, CL; Mitsuya, H; Mueller, BU; Murphy, R; Pizzo, PA; Zuckerman, J1

Trials

1 trial(s) available for kynostatin 272 and Disease Models, Animal

ArticleYear
Pharmacokinetics of the protease inhibitor KNI-272 in plasma and cerebrospinal fluid in nonhuman primates after intravenous dosing and in human immunodeficiency virus-infected children after intravenous and oral dosing.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:7

    Topics: Administration, Oral; Adolescent; Animals; Child; Child, Preschool; Disease Models, Animal; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infusions, Intravenous; Macaca mulatta; Male; Oligopeptides

1998